Lifecore Biomedical, Inc. LFCR

4.20 (0.09) (2.10%) as of 25 Sep
Market cap
$162.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

May '16 May '17 May '18 May '19 May '20 May '21 May '22 May '23 May '24 May '25
Cash and Short Term Investments
9.89 6.00 2.90 1.08 0.36 1.16 0.99 19.09 8.46 8.27
Receivables
46.41 45.90 53.88 69.57 76.21 41.43 38.31 29.02 27.08 28.69
Inventory
25.54 23.62 31.82 54.13 66.31 63.08 36.00 40.84 39.98 32.29
Other current assets
4.47 5.76 8.47 6.26 14.23 42.66 7.05 5.08 4.07 6.98
Total current assets
86.30 81.28 97.06 133.04 157.11 148.32 116.67 93.88 81.03 85.68
Property, Plant, Equpment (Net)
120.88 133.22 159.62 200.03 192.34 120.29 118.67 134.39 149.17 129.01
Long-Term Investments
62.70 63.60 66.50 61.10 56.90 45.10 — — — —
Goodwill and Intangible Assets (Total)
71.02 77.32 76.35 121.99 107.49 59.55 18.08 18.08 18.08 18.08
Long-term assets (Other)
1.75 2.92 5.16 2.93 2.16 3.53 2.89 2.92 5.68 6.58
Total non-current assets
256.35 277.33 307.64 386.05 384.21 354.60 158.04 159.67 172.93 153.67
Total Assets
342.65 358.61 404.70 519.09 541.31 502.92 274.70 253.55 253.96 239.34
Accounts Payable
30.90 24.53 34.67 53.97 51.65 16.30 12.95 22.10 16.33 8.22
Accrued Expenses
5.46 7.51 9.98 10.69 9.03 7.75 8.94 4.15 22.54 21.96
Current Part of Debt
11.37 7.94 31.94 61.79 88.95 29.00 138.18 0.58 0.77 —
Current Revenue (Deferred)
0.83 0.31 2.63 0.50 0.35 0.64 0.92 4.06 2.11 —
Total current liabilities
56.34 51.45 88.38 137.09 164.39 101.89 176.58 39.29 38.87 30.18
Long Term Debt (Total)
49.78 46.03 41.00 87.19 101.36 164.90 9.98 165.97 149.13 151.99
Non-current Revenue (Deferred)
— — — — — — — 2.94 4.70 —
Long Term Tax Liability (Deferred)
22.44 24.58 17.49 19.39 13.59 6.14 0.13 0.38 0.54 —
Non-current Liabilities (Other)
1.74 8.39 5.28 1.74 4.55 2.87 0.19 0.17 12.06 9.74
Total non-current liabilities
73.96 79.00 63.77 111.86 145.88 198.25 10.30 179.17 161.19 161.73
Total liabilities
130.30 130.46 152.14 248.95 310.27 300.14 186.88 218.46 200.06 191.91
Additional Paid In Capital
137.24 141.68 142.09 160.34 162.58 165.53 167.35 174.28 177.81 206.54
Preferred Stock (Total)
— — — — — — — 39.32 42.59 46.10
Common Stock (Net)
0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04
Retained Earnings
73.46 84.47 109.30 109.71 71.25 38.58 (78.97) (178.54) (166.52) (205.24)
Common Equity (Total)
212.35 228.15 252.56 270.14 231.04 202.78 87.82 (4.23) 11.32 1.34
Shareholders Equity (Total)
212.35 228.15 252.56 270.14 231.04 202.78 87.82 35.09 53.90 47.43
Shareholders Equity and Liabilities (Total)
342.65 358.61 404.70 519.09 541.31 502.92 274.70 253.55 253.96 239.34
Shares (Common)
27.15 27.50 27.70 29.10 29.22 29.33 29.51 30.32 30.56 37.03
Shares (Preferred)
— — — — — — 0.04 0.04 0.04 0.05
Shareholders Equity (Tangible)
141.33 150.83 176.21 148.16 123.55 143.24 69.74 17.01 35.82 29.35
Net Debt
51.26 47.97 70.04 147.90 189.96 192.74 147.17 147.45 141.44 143.73
Total Debt
61.15 53.97 72.94 148.98 190.32 193.90 148.16 166.55 149.90 151.99

Fold the line items

In millions of $ except per-share values · columns are period end dates